BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16420966)

  • 1. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
    Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats.
    Túnez I; Feijóo M; Collado JA; Medina FJ; Peña J; Muñoz Mdel C; Jimena I; Franco F; Rueda I; Muntané J; Montilla P
    Life Sci; 2007 Mar; 80(13):1221-7. PubMed ID: 17266993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
    Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid.
    Lagoa R; Lopez-Sanchez C; Samhan-Arias AK; Gañan CM; Garcia-Martinez V; Gutierrez-Merino C
    J Neurochem; 2009 Oct; 111(2):473-87. PubMed ID: 19682208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease.
    Túnez I; Montilla P; Del Carmen Muñoz M; Feijóo M; Salcedo M
    J Pineal Res; 2004 Nov; 37(4):252-6. PubMed ID: 15485551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A; Akula KK; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D; Hartwig JM; Soares FA; Farina M
    Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats.
    Al Mutairy A; Al Kadasah S; Elfaki I; Arshaduddin M; Malik D; Al Moutaery K; Tariq M
    Neurotoxicol Teratol; 2010; 32(2):226-33. PubMed ID: 19755148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered striatal vulnerability to 3-nitropropionic acid in rats due to sex hormone levels during late phase of brain development.
    Mogami M; Hayashi Y; Masuda T; Kohri K; Nishino H; Hida H
    Neurosci Lett; 2008 May; 436(3):321-5. PubMed ID: 18406525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain.
    Kumar P; Kumar A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):100-8. PubMed ID: 19022325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
    Duan W; Guo Z; Mattson MP
    Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
    Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease.
    Túnez I; Drucker-Colín R; Jimena I; Medina FJ; Muñoz Mdel C; Peña J; Montilla P
    J Neurochem; 2006 May; 97(3):619-30. PubMed ID: 16524377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
    Kumar P; Kumar A
    Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes.
    Duran-Vilaregut J; Del Valle J; Manich G; Junyent F; Camins A; Pallàs M; Pelegrí C; Vilaplana J
    Neurochem Int; 2010 Feb; 56(3):443-50. PubMed ID: 19969037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
    Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.